retatrutide clinical trial phase ESC 2024: improves lipid and cardiovascular risk profile in II Lilly's 'triple G' agonist triumphs

One MDL focuses on gastrointestinal injuries such as gastroparesis, bowel obstruction, ileus, and severe vomiting, while the second MDL involves claims alleging semaglutide medications caused non-arteritic anterior ischemic optic neuropathy (NAION) and permanent vision loss

Compounded or brand-name

Refined carbohydrates involve processed grains, refined flours, starches, and added sugars

For instance, the duration since or sequence of CKD and type 2 diabetes diagnoses is difficult to ascertain as individuals may have been diagnosed previously while on another health insurance plan or may have experienced gaps in coverage

Early weight loss includes significant water as glycogen stores deplete and sodium intake typically decreases

GPs are being encouraged to talk to patients about the safety of unapproved weight-loss medications, following new concerns over unregistered GLP-1 products being promoted online